Published: 23 Jan 2013 11:59 GMT+01:00 | Print version
Updated: 23 Jan 2013 11:59 GMT+01:00
Basel-based pharmaceutical group Novartis reported on Wednesday a net profit of $9.6 billion for 2012, up four percent from the previous year, but posted slightly lower sales amid stronger competition from generic drugs.
The company, which also announced that its chairman of 17 years, Daniel Vasella, was leaving, said in a statement it had achieved net sales of $56.7 billion.
That was a three percent drop from 2011, but still narrowly beat the expectations of analysts polled by the AWP financial agency, who anticipated sales of $56.5 billion.
Novartis's important Pharma division, meanwhile, saw sales slip one percent to $32.1 billion dollars amid swelling competition from generic drugs.
The price of shares in Novartis surged by 2.5 percent to 61.60 francs a share in morning trading on a Swiss stock exchange up 0.66 percent.
Like the rest of the pharmaceutical industry, the company has also had to deal with growing pricing pressure at a time when crisis-hit countries are increasingly being forced to slash health expenditures.
Company chief executive Joseph Jimenez meanwhile insisted that "Novartis maintained strong momentum in innovation in 2012," pointing out that the Basel-based company had secured 17 major approvals in 2012.
"Our pipeline is expected to deliver a record number of near-term approvals and filings, and . . . we anticipate 14 products to reach blockbuster status by 2017, up from eight in 2012," he said.
For 2013, Novartis said it expected to see sales in line with last year in constant currencies, despite an impact of up to $3.5 billion from generic competition.
Novartis also announced that chairman Vasella had decided not to stand for re-election at the next annual meeting, on February 22nd.
Dr. Joerg Reinhardt, who currently heads Bayer HealthCare, has been put forward for the job, Novartis said, adding that he would take over on August 1st, and that vice-chairman Ulrich Lehner would lead the board in the interim.
Tibetan exiles in Bern on Friday urged Swiss authorities to take China to task for its human rights record during a landmark visit by Premier Li Keqiang focused squarely on a trade deal. READ () »
Chinese Premier Li Keqiang on Friday hailed a free trade deal with Switzerland as a landmark achievement, saying it had "huge meaning" for global trade and underscored Beijing's growing openness to the world. READ () »
Steffan Millius grips his sword and makes his way through the throngs of people crowding into Appenzell's central square to take part in Switzerland's famous direct democracy in perhaps its purest form. READ () »
A University of Neuchâtel professor under fire for alleged plagiarism is now facing accusations of falsifying his CV. READ () »
The sailboat of Swiss explorer and adventurer Mike Horn was ordered seized by a Marseille court in a southern French port over a dispute involving a naval architect, according to a media report. READ () »
Geneva cantonal police raided eight erotic massage parlours on Tuesday for an investigation into tax fraud allegedly amounting to several million francs. READ () »
A diamond necklace from Geneva jeweller De Grisogono worth 2.5 million francs was reported stolen from Cannes on Thursday, just days after thieves made off with 1.4 million francs' worth of bling from Chopard, another jeweller from the Swiss city. READ () »
Chinese Premier Li Keqiang sees a looming free-trade deal with Switzerland as a touchstone for Beijing's growing ties with foreign nations, he told a Swiss newspaper on Thursday ahead of a landmark visit to Europe. READ () »
Whether you have ever or never visited the Netherlands, the country that crowned a new monarch this year is also celebrating a wealth of special jubilees in its popular capital. Here’s the lowdown on why Amsterdam is the place to be in 2013. READ () »
After a wetter than usual start to spring, Switzerland is bracing for a return to wintry conditions and snow in some locations over the next few days. READ () »